A randomised controlled study of the effect of dietary sodium modification on asthma control

ISRCTN ISRCTN80771653
DOI https://doi.org/10.1186/ISRCTN80771653
Secondary identifying numbers Version 1
Submission date
02/08/2005
Registration date
10/08/2005
Last edited
07/05/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Andrew Fogarty
Scientific

Dept of Epidemiology and Public Health
University of Nottingham
Clinical Science Building
Nottingham City Hospital
Nottingham
NG5 1PB
United Kingdom

Phone +44 (0)115 8404782
Email andrew.fogarty@nottingham.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesLow dietary sodium improves asthma control.
Ethics approval(s)Ethics approval received from the MREC for Wales in September 2005 (ref: 05/MRE09/72).
Health condition(s) or problem(s) studiedAsthma
InterventionLow sodium diet versus normal sodium diet.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Dietary sodium
Primary outcome measure1. Bronchial reactivity, measured at baseline visit and six weeks later
2. Autonomic function assessed by heart rate variability, measured at baseline visit and six weeks later
Secondary outcome measures1. Peak flow rate, measured for one week before baseline visit and for the six weeks of the study
2. Symptom score, measured for one week before baseline visit and for the six weeks of the study
3. Spirometry, measured at baseline visit and six weeks later
4. Skin prick sensitivity, measured at baseline visit and six weeks later
5. Carbon monoxide, measured at baseline visit and six weeks later
Overall study start date01/01/2006
Completion date01/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants220
Key inclusion criteria1. Aged 18 - 65 years, either sex
2. Asthma
3. Bronchial reactivity to methacholine
Key exclusion criteria1. Oral steroids
2. Diuretics or drug that affects sodium
3. Current or planned pregnancy
4. Other serious illness
5. Recent exacerbation of asthma
Date of first enrolment01/01/2006
Date of final enrolment01/12/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Dept of Epidemiology and Public Health
Nottingham
NG5 1PB
United Kingdom

Sponsor information

University of Nottingham (UK)
University/education

University Park
Nottingham
NG7 2RP
England
United Kingdom

Phone +44 (0)115 9515679
Email paul.cartledge@nottingham.ac.uk
ROR logo "ROR" https://ror.org/01ee9ar58

Funders

Funder type

Charity

Asthma UK (UK) (2005 grant)
Private sector organisation / Other non-profit organizations
Alternative name(s)
Asthma UK, Asthma + Lung UK
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 15/07/2008 Yes No